Asia-Pacific Veterinary Healthcare Market - Growth, Trends, and Forecast (2020 - 2025)

The Asia-Pacific Veterinary Healthcare market is segmented by Product, Animal Type, and Geography

Market Snapshot

Study Period:

2018-2024

Base Year:

2019

Major Players:

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Market Overview

  • Risk of emerging zoonosis is the major factor fueling the growth of the Asia-Pacific veterinary healthcare market.
  • According to the Ministry of Agriculture, Food, and Rural Affairs (MAFRA), in 2016, the emergence of bird flu in South Korea resulted in the culling of over 30 million chickens and ducks across the country, primairly as a preventive measure.This, in turn, resulted in a shortage of eggs in the domestic market.
  • Other factors responsible for the growth of the market studied include an increase in the number of farm animals and growing technological advancements in animal healthcare.
  • According to the National Dairy Development Board, in 2017, in India, the cattle population was valued at 156.7 million and the nation has one of the largest animal husbandry sectors in the world, along with the largest livestock population (520.6 million).
  • However, the use of counterfeit medicines, lack of infrastructure, and funding are restraining the growth of the  market studied.

Scope of the Report

As per the scope of this report, the AsiaPacific veterinary healthcare market comprises of therapeutic products and solutions for companion and farm animals. Companion animals can be tamed or adopted for companionship or as house/office guards, and farm animals are raised for meat and milk-related products. Companion animals include canine, feline, and equine. Farm animals are bovine, poultry, and porcine.

By Product
By Therapeutics
Vaccines
Parasiticides
Anti-infectives
Medical Feed Additives
Other Therapeutics
By Diagnostics
Immunodiagnostic Tests
Molecular Diagnostics
Diagnostic Imaging
Clinical Chemistry
Other Diagnostics
By Animal Type
Dogs and Cats
Horses
Ruminants
Swine
Poultry
Other Animals
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Molecular Diagnostics Segment is expected to Lead the Market

The veterinary molecular diagnostics segment is expected to witness growth over the forecast period, due to the increasing academic research activities pertaining to veterinary molecular diagnostics and investigational techniques, primarily to target epidemic-like conditions in companion and farm animals. Furthermore, there is an increase in the application of molecular diagnostic techniques, primarily for the identification of bacterial diseases, like Brucella, through enzyme-linked immunosorbent assay (ELISA), Rose Bengal Plate Test (RBPT), and PCR-based diagnosis. The department of veterinary medical sciences at the Graduate School of Agricultural and Life Sciences, University of Tokyo, is involved in conducting advanced research at molecular, cellular, and in vivo levels, in order to fully understand vital processes of normal and diseased animals. Overall, the Asia-Pacific veterinary molecular diagnostics segment is likely to register significant growth over the forecast period. Though the market is in the nascent stage, there are tremendous opportunities for market growth, primarily due to increased activity in academic research and government funding.

To understand key trends, Download Sample Report

Competitive Landscape

The players in the Asia-Pacific veterinary healthcare market are primarily focusing on various growth strategies, such as collaborations, partnerships, agreements, mergers, and acquisitions, in order to enhance their market presence. Major market players include Bayer Healthcare, Boehringer Ingelheim, Ceva Animal Health, Inc., Elanco (Eli Lilly and Company), Merck Animal Health, and Zoetis and Virbac Corporation, among others.

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

      1. 4.1.1 Advanced Technology is Leading to Innovations in Animal Healthcare

      2. 4.1.2 Increasing Productivity at the Risk of Emerging Zoonosis

    2. 4.2 Market Restraints

      1. 4.2.1 Increasing Cost of Animal Testing and Veterinary Services

      2. 4.2.2 Lack of Infrastructure and Funding

      3. 4.2.3 Use of Counterfeit Medicines

    3. 4.3 Porter's Five Forces Analysis

      1. 4.3.1 Threat of New Entrants

      2. 4.3.2 Bargaining Power of Buyers/Consumers

      3. 4.3.3 Bargaining Power of Suppliers

      4. 4.3.4 Threat of Substitute Products

      5. 4.3.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 By Therapeutics

        1. 5.1.1.1 Vaccines

        2. 5.1.1.2 Parasiticides

        3. 5.1.1.3 Anti-infectives

        4. 5.1.1.4 Medical Feed Additives

        5. 5.1.1.5 Other Therapeutics

      2. 5.1.2 By Diagnostics

        1. 5.1.2.1 Immunodiagnostic Tests

        2. 5.1.2.2 Molecular Diagnostics

        3. 5.1.2.3 Diagnostic Imaging

        4. 5.1.2.4 Clinical Chemistry

        5. 5.1.2.5 Other Diagnostics

    2. 5.2 By Animal Type

      1. 5.2.1 Dogs and Cats

      2. 5.2.2 Horses

      3. 5.2.3 Ruminants

      4. 5.2.4 Swine

      5. 5.2.5 Poultry

      6. 5.2.6 Other Animals

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Zoetis Inc.

      2. 6.1.2 Merck Animal Health

      3. 6.1.3 Vetoquinol

      4. 6.1.4 Elanco

      5. 6.1.5 Bayer Healthcare

      6. 6.1.6 Ceva Animal Health Inc.

      7. 6.1.7 Virbac

      8. 6.1.8 IDEXX Laboratories

      9. 6.1.9 Phibro Animal Health

      10. 6.1.10 Boehringer Ingelheim International GmbH

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers - Business Overview, Financials, Products and Strategies, and Recent Developments

Related Reports